跳至主要内容
临床试验/NCT04807543
NCT04807543已完成2 期

Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes

Ain Shams University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年1月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
100
试验地点
1
主要终点
prolongation of the pregnancy until a favorable gestational age

研究概览

简要总结

The aim of the study is to assess the efficacy of 17-hydroxyprogesterone caproate (17P) therapy on the latency period in pregnant women with Preterm premature rupture of membranes.

详细描述

After taking informed written consent, the recruited patients will be subjected to the following:

  1. Detailed history
  • Personal History: Name, age ,residence ,special habits of medical importance
  • Obstetric history: first day of last menstrual period for accurate estimation of gestational age and antenatal care
  • Past history: history of any medical disorder or surgical history with particular emphasis on prior PPROM or preterm labor
  • History of the present pregnancy: Medical or surgical condition to define high risk pregnancy.
  1. Examination of the patients General examination: blood pressure, pulse, temperature

Abdominal examination:

  • Inspection: fundal level, scars, umbilicus.

  • Palpation: presence of contractions, fetal lie and presentation.

  • Pelvic Examination only by sterile speculum to exclude cord prolapse , bloody liquor and cervical dilatation and effacement

  • Non stress test to ensure reassuring fetal well being

  • Ultrasound examination to:-

  • Assess fetal viability.

  • Amniotic fluid index.

  • Determine gestational age.

  • Exclude major anomalies.

  • Placental location.

  1. Baseline laboratory investigations:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Singleton pregnancy
  • Gestational age between 24 and 34 weeks

排除标准

  • Medical or obstetric conditions that could put them at risk for uterine atony , postpartum hemorrhage AND infection, such as
  • Emergency Cesarean section.
  • Chorioamnionitis.
  • Placenta previa.
  • Multiple gestation.
  • Preeclampsia.
  • Macrosomia.
  • Non reassuring fetal status or fetal distress
  • Presence of fetal anomalies incompatable with life
  • Woman with antepartum haemorrhage
  • Diagnosis of Established preterm labor

研究组 & 干预措施

study group

Active Comparator

17-hydroxyprogesterone caproate (17P) (250 mg in castor oil, 1 mL total volume)intramuscular injection

干预措施: 17-hydroxyprogesterone caproate (Drug)

control group

Placebo Comparator

castor oil, 1 mL total volume intramuscular injection

干预措施: Castor Oil (Drug)

结局指标

主要结局

prolongation of the pregnancy until a favorable gestational age

时间窗: 10 to 12 weeks (up to 34.0 weeks of gestation or documentation of fetal lung maturity at 32.0 to 33.9 weeks.)

The most common method of measuring gestational age in weeks is by calculating the time since the last menstrual period based on dates provided by a woman at the first prenatal visit IF not available first trimester Ultrasound will be used

次要结局

  • Composite neonatal morbidity(1 week (from delivery to 1 week post Natal))
  • Latency .(10 to 12 weeks (interval in weeks from randomization to delivery))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验